Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), invested Rs 40 crore, while Alkemi Growth Capital, a healthcare and consumer wellness-focused venture fund, invested Rs 25 crore, the company said in a release.
News
ZeroHarm Sciences raises Rs 65 cr from Kotak Life Sciences Fund, Alkemi Growth Capital
February 26, 2026Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), invested Rs 40 crore, while Alkemi Growth Capital, a healthcare and consumer wellness-focused venture fund, invested Rs 25 crore, the company said in a release.